Bladder cancer angiogenesis, its role in recurrence, stage progression and as a therapeutic target

被引：12

作者：

Crew, JP

OBrien, TS

Harris, AL

机构：

[1] UNIV OXFORD,JOHN RADCLIFFE HOSP,INST MOLEC MED,IMPERIAL CANC RES FUND,OXFORD OX3 9DU,ENGLAND

[2] CHURCHILL HOSP,DEPT UROL,OXFORD OX3 7LJ,ENGLAND

来源：

CANCER AND METASTASIS REVIEWS | 1996年 / 15卷 / 02期

关键词：

angiogenesis; bladder cancer; antiangiogenic therapy; VEGF; prognosis; stage progression; thymidine phosphorylase;

D O I：

10.1007/BF00437475

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

In this article we review the role of angiogenesis in bladder tumour development and its putative role in determining tumour progression and recurrence. The potential value of antiangiogenic therapy in the disease is also discussed.

引用

页码：221 / 230

页数：10

共 82 条

[1]

BADALAMENT RA, 1992, UROL CLIN N AM, V19, P485

[2] VASCULAR-PERMEABILITY FACTOR (VASCULAR ENDOTHELIAL GROWTH-FACTOR) GENE IS EXPRESSED DIFFERENTIALLY IN NORMAL-TISSUES, MACROPHAGES, AND TUMORS [J].

BERSE, B ;

BROWN, LF ;

VANDEWATER, L ;

DVORAK, HF ;

SENGER, DR .

MOLECULAR BIOLOGY OF THE CELL, 1992, 3 (02) :211-220

[3]

Bicknell R, 1992, Semin Cancer Biol, V3, P399

[4]

Bochner Bernard H., 1995, Journal of Urology, V153, p456A

[5] CANCER STATISTICS, 1993 [J].

BORING, CC ;

SQUIRES, TS ;

TONG, T .

CA-A CANCER JOURNAL FOR CLINICIANS, 1993, 43 (01) :7-26

[6] A STRUCTURE-ACTIVITY ANALYSIS OF ANTAGONISM OF THE GROWTH-FACTOR AND ANGIOGENIC ACTIVITY OF BASIC FIBROBLAST GROWTH-FACTOR BY SURAMIN AND RELATED POLYANIONS [J].

BRADDOCK, PS ;

HU, DE ;

FAN, TPD ;

STRATFORD, IJ ;

HARRIS, AL ;

BICKNELL, R .

BRITISH JOURNAL OF CANCER, 1994, 69 (05) :890-898

[7]

BROWN LF, 1993, AM J PATHOL, V143, P1255

[8]

BROWN LF, 1993, CANCER RES, V53, P4727

[9] VASCULAR-PERMEABILITY FACTOR MESSENGER-RNA AND PROTEIN EXPRESSION IN HUMAN KIDNEY [J].

BROWN, LF ;

BERSE, B ;

TOGNAZZI, K ;

MANSEAU, EJ ;

VANDEWATER, L ;

SENGER, DR ;

DVORAK, HF ;

ROSEN, S .

KIDNEY INTERNATIONAL, 1992, 42 (06) :1457-1461

[10]

CHEN C, 1995, CANCER RES, V55, P4230

← 1 2 3 4 5 6 7 8 9 →